+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Arthritis Drug"

From
From
Psoriatic Arthritis Pipeline Analysis Report 2025 - Product Thumbnail Image

Psoriatic Arthritis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Psoriatic Arthritis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Psoriatic Arthritis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Psoriatic Arthritis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Psoriatic Arthritis: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 43 Pages
  • Global
From
From
From
From
From
From
Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
KEVZARA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEVZARA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease. The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more